UNSPSC 51401522: Ethyl dirazepate

This classification denotes a benzodiazepine with the molecular formula C18H14Cl2N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 74FAA305EW, chemically known as ethyl 7-chloro-5-(o-chlorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepine-3-carboxylate. but generally known as ethyl dirazepate, which bears US NIH Compound Identifier 208941. European Medicines Agency schedules Ethyl dirazepate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07289MIG.

UNSPSC 51401522 Ethyl dirazepate is a Commodity code for a specific pharmaceutical compound, but recent state and local procurement activity under this code does not reflect purchases of ethyl dirazepate itself. Instead, the only recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health support, a mismatch with the code's nominal pharmaceutical scope. The code shows little relevant recent activity aligned with its intended product line.

Seminole County, Florida posted the sole recent opportunity on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding. Quarterly deliveries are to be made to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. The contract carries a two-year initial term with a one-year renewal option, a three-month probationary period, and potential FEMA funding, which imposes federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Bidders must comply with E-Verify, drug-free workplace certification, and specified insurance requirements. No set-aside designations or disadvantaged-enterprise restrictions are noted. The mismatch between the code definition and the actual procurement scope suggests this code may not be the primary vehicle for state and local naloxone or medical-supply purchases, warranting verification of the correct UNSPSC classification for firms pursuing opportunities in this space.